je.st
news
twoXAR Joins Stanford University In Hunt For Medicines Targeting Rare Diseases
2016-05-03 03:04:31| drugdiscoveryonline News Articles
twoXAR, Inc., a company dedicated to improving health through computation, recently announced a collaboration with Joyce Teng, MD, PhD, of the Department of Dermatology at Stanford University to support research focused on the identification of drug candidates targeting rare disorders such as lymphatic malformation and epidermolysis bullosa simplex (EBS)
Tags: university
rare
diseases
hunt
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||